Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study

Eric Lawitz, Charles S. Landis, Steven L. Flamm, Maurizio Bonacini, Grisell Ortiz-Lasanta, Jonathan Huang, Jie Zhang, Brian J. Kirby, Shampa De-Oertel, Robert H. Hyland, Anu O. Osinusi, Diana M. Brainard, Richard Robson, Benedict J. Maliakkal, Stuart C. Gordon, Edward J. Gane

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences